From: Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
CTRL | IND | PD 1-2 | PD 2.5-4 | |
---|---|---|---|---|
No. of patients | 47 | 11 | 46 | 27 |
Age in years | 60.4 ± 10.9 (45.0 to 83.0) | 59.2 ± 9.0 (45.0 to 75.0) | 60.3 ± 9.2 (44.0 to 77.0) | 63.9 ± 10.1 (49.0 to 83.0) |
Disease duration, months | - | - | 25.8 ± 15.1 | 54.0 ± 41.7 |
UPDRS III score | - | - | 19.0 ± 5.6 | 38.0 ± 10.6 |
H&Y stage | - | - | 1.6 ± 0.4 | 3.0 ± 0.5 |
PD medications | - | - | None: 65.2% | None: 7.4% |
DA: 19.6% | DA: 22.2% | |||
LD: 4.3% | LD: 33.3% | |||
LD + DA: 10.9% | LD + DA: 37.1% | |||
Motor fluctuations | - | - | 7/46 | 17/27 |
Albumin ratio (× 10-3) | 5.2 (2.3 to 13.1) | 5.8 (3.4 to 8.1) | 5.6 (2.6 to 16.2) | 8.2 (3.0 to 21.2) |
IgG ratio (× 10-3) | 2.7 (1.1 to 6.9) | 2.8 (1.1 to 4.0) | 2.7 (1.1 to 9.5) | 3.9 (1.6 to 10.4) |